Medacta to Introduce NextAR(TM): First FDA-Cleared Augmented Reality-Based Surgical Platform for Total Knee Replacement (press release)
Medacta today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for its NextARTM Augmented Reality based surgical platform for total knee arthroplasty (TKA) procedures.
The NextARTM TKA is the first application of a new platform technology, which will be extended to hip, shoulder and spine procedures, designed and engineered with Artificial Intelligence and Machine Learning that make pre-operative CT-based planning and analysis efficient and precise.
The NextARTM TKA Application has the goal to improve efficiency and precision in total knee replacement and deliver personalized planning, with low upfront capital investment required by clinics and hospitals, as well as economic benefits to the healthcare system through OR efficiency and low cost per procedure. This new platform will be an optimal solution particularly for U.S. ambulatory surgery centers (ASCs), which provide same-day surgical care.
The Augmented Reality glasses provided with the NextARTM Platform allow the surgeon to visualize...
